Ronan Martin Murphy net worth and biography

Ronan Murphy Biography and Net Worth

Director of Icon

Mr. Rónán Murphy has served as a Non-Executive Director of ICON plc since October 2016. He was appointed as Lead Independent Director in January 2019.

Mr. Murphy is the former Senior Partner of PwC Ireland. He was elected Senior Partner in 2007 and was re-elected for a further four year term in 2011. Following completion of the maximum two terms, Mr. Murphy retired from the firm in 2015. Mr. Murphy was also a member of the PwC EMEA Leadership Board for a five year period from 2010 to 2015. Mr. Murphy joined PwC in 1980 and was admitted to the Partnership in 1992.

Mr. Murphy currently serves as a non-executive director of Norbrook Holdings Limited. Mr. Murphy previously served as Chair of Greencoat Renewables PLC and as a council member of the ESRI, as Chair of Business in the Community Ireland and as a non executive Director of Davy Stockbrokers. He is also a founding Board Member of the British Irish Chamber of Commerce. Mr. Murphy completed a Bachelor of Commerce and Masters in Business Studies at University College Dublin before qualifying as a chartered accountant in 1982.

What is Ronan Martin Murphy's net worth?: The estimated net worth of Ronan Martin Murphy is at least $649.22 thousand as of August 11th, 2026. Murphy owns 3,847 shares of Icon stock worth more than $649,220 as of August 17th. This net worth estimate does not reflect any other investments that Murphy may own. Learn More about Ronan Martin Murphy's net worth.
How do I contact Ronan Martin Murphy?: The corporate mailing address for Murphy and other Icon executives is SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN, DUBLIN L2, 00000. Icon can also be reached via phone at (531) 291-2000. Learn More on Ronan Martin Murphy's contact information.
Has Ronan Martin Murphy been buying or selling shares of Icon?: During the last quarter, Ronan Martin Murphy has sold $138,167.89 in Icon stock. Most recently, Ronan Martin Murphy sold 841 shares of the business's stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $164.29, for a transaction totalling $138,167.89. Following the completion of the sale, the director now directly owns 3,847 shares of the company's stock, valued at $632,023.63. Learn More on Ronan Martin Murphy's trading history.
Who are Icon's active insiders?: Icon's insider roster includes Barry Balfe (CEO), Brennan Brendan (CFO), Bernard Clerkin (CFO), John Climax (Director), Linda Grais (Director), Eugene Mccague (Director), Ronan Murphy (Director), Ciaran Murray (Director), and Anne Whitaker (Director). Learn More on Icon's active insiders.
Are insiders buying or selling shares of Icon?: In the last year, insiders at the medical research company sold shares 8 times. They sold a total of 9,531 shares worth more than $1,565,763.95. The most recent insider tranaction occured on August, 11th when Director Linda Grais sold 841 shares worth more than $138,167.89. Insiders at Icon own 44.0% of the company. Learn More about insider trades at Icon.
Information on this page was last updated on 8/11/2026.

Ronan Martin Murphy Insider Trading History at Icon

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/11/2026	Sell	841	$164.29	$138,167.89	3,847

Ronan Martin Murphy Buying and Selling Activity at Icon

Icon Company Overview

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Today's Range

Now: $169.45

$161.16

$169.73

50 Day Range

MA: $162.50

$140.73

$180.24

2 Week Range

Now: $169.45

$66.57

$203.91

Volume

485,724 shs

Average Volume

1,365,400 shs

Market Capitalization

$12.97 billion

P/E Ratio

39.78

Dividend Yield

N/A

Beta

1.21